ALKS vs TMO · P/E 14, rev $1.56B vs P/E 24, rev $44.56B
Alkermes Plc (ALKS) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ALKS and TMO stock pages for the full models.
Not investment advice.